Pharma Focus Asia
MasterControl - Avoid Falling Behind the Pharma Market

HUTCHMED Introduces Novel Fruquintinib in Combination with Sintilimab for Advanced Endometrial Cancer

HUTCHMED has introduced novel fruquintinib and sintilimab (a PD-1 antibody). The combination of fruquintinib and sintilimab is a promising development for patients with advanced endometrial cancer with pMMR1 tumours who have failed at least one line of platinum-based therapy. 

Fruquintinib is an oral inhibitor that specifically targets vascular endothelial growth factor receptors (VEGFR) -1, -2, and -3. VEGFR inhibitors are essential in blocking tumour angiogenesis.

Fruquintinib is aimed to improve kinase selectivity, minimising off-target toxicities, and enhancing tolerability while providing consistent target coverage. It has shown good tolerability in patients and is being studied in combination with other anti-cancer therapies.

On the other hand, sintilimab is classified as an immunoglobulin G4 monoclonal antibody that specifically targets PD-1 molecules found on T-cells' surfaces. By blocking the PD-1/PD-Ligand 1 (PD-L1) pathway, it reactivates T-cells to attack cancer cells.

The breakthrough therapy designation (BTD) granted by China's National Medical Products Administration (NMPA) signifies the potential of this combination in treating advanced endometrial cancer patients.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Increasing the likelihood of your drug approvalMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® productsMedical Fair Thailand 20235th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023
MasterControl - 6 Essential Features in an eQMS